{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:12:00Z","timestamp":1790932320868,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":5643,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1538-7836.2007.02503.x","type":"journal-article","created":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T11:57:52Z","timestamp":1183982272000},"page":"151-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"S1","title":["Phenotypic heterogeneity in severe hemophilia"],"prefix":"10.1016","volume":"5","author":[{"given":"H.M.","family":"VAN DEN BERG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.G.","family":"DE GROOT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"FISCHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0010","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B. Review","volume":"24","author":"Bolton-Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2516.2005.01124.x","article-title":"Variability in clinical phenotype of severe haemophilia; the role of the first joint bleed","volume":"11","author":"Van Dijk","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","article-title":"A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group","volume":"236","author":"Aledort","year":"1994","journal-title":"J Intern Med"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2516.1996.tb00156.x","article-title":"Types of bleeding seen during the first 30\u2003months of life I children with severe hemophilia A and B","volume":"2","author":"Onwuzurike","year":"1996","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1651-2227.1990.tb11438.x","article-title":"Diagnostic symptoms of severe and moderate haemophilia A and B","volume":"79","author":"Ljung","year":"1990","journal-title":"Acta Paediatrc Scand"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1055\/s-0037-1614159","article-title":"Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia","volume":"84","author":"Fischer","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0040","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood-2004-05-2008","article-title":"Thirty years of hemophilia treatment in the Netherlands, 1972-2001","volume":"104","author":"Plug","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty-five years experience of prophylactic therapy in severe haemophilia A and B","volume":"232","author":"Nilsson","year":"1992","journal-title":"J Int Med"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0050","first-page":"494","article-title":"Factor VIII half-life and clinical phenotype of severe hemophilia A","volume":"90","author":"Van Dijk","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1973.tb01680.x","article-title":"A three-year study of adolescent boys suffering from haemophilia and allied disorders","volume":"24","author":"Rainsford","year":"1973","journal-title":"B J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2516.2000.00358.x","article-title":"Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group","volume":"6","author":"Molho","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.ATV.0000046238.23903.FC","article-title":"The dynamics of thrombin formation","volume":"23","author":"Mann","year":"2003","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V88.4.1183.bloodjournal8841183","article-title":"Moderation of hemophilia A phenotype by the factor V R506Q mutation","volume":"88","author":"Nichols","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0037-1615679","article-title":"Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors","volume":"85","author":"Escuriola-Ettingshausen","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2141.1995.tb05325.x","article-title":"Inter-individual variation of half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand antigen levels","volume":"91","author":"Fijnvandraat","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0037-1613759","article-title":"The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A","volume":"83","author":"Vlot","year":"2000","journal-title":"Thromb Haemost"},{"issue":"Suppl. 4","key":"10.1111\/j.1538-7836.2007.02503.x_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2006.01331.x","article-title":"Drug dosing in children \u2013 special consideration","volume":"12","author":"Pencharz","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0100","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2141.1993.tb04670.x","article-title":"Mutations in haemophilia A","volume":"83","author":"Schwaab","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2003-37936","article-title":"The molecular basis of hemophilia a: genotype\u2013phenotype relationships and inhibitor development","volume":"29","author":"Goodeve","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0037-1615636","article-title":"Mutation profiling in haemophilia A","volume":"85","author":"Oldenburg","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(94)91165-7","article-title":"Factor VIII gene rearrangements in patients with severe haemophilia A","volume":"343","author":"Goodeve","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1613023","article-title":"The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII: C)","volume":"87","author":"Shima","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1614109","article-title":"Phenotyping the clotting system","volume":"84","author":"Hemker","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-0037-1613868","article-title":"The thrombogram: monitoring thrombin generation in platelet-rich plasma","volume":"83","author":"Hemker","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1538-7836.2004.00528.x","article-title":"Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders","volume":"2","author":"Sorensen","year":"2004","journal-title":"Patterns of response to recombinant factor VIIa J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Dargaud","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0145","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2516.2002.00686.x","article-title":"Paradoxysmal hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia","volume":"8","author":"Grunewald","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inibition of fibrinolysis by recombinant factor VIIa in plasma form patients with severe hemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2516.2000.00422.x","article-title":"Participation in sports by Dutch persons with haemophilia","volume":"6","author":"Heijnen","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2516.2006.01214.x","article-title":"Exercise may decrease further destruction in the adult haemophilic joint","volume":"12","author":"Harris","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2516.2003.00679.x","article-title":"Physical training increases isometric muscular strength and proprioceptive performance in haemophilic subjects","volume":"9","author":"Hilberg","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0170","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/rheumatology\/39.11.1180","article-title":"Are differences in interleukin 10 production associated with joint damage?","volume":"39","author":"Huizinga","year":"2000","journal-title":"Rheumatology"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0175","first-page":"1960","article-title":"Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis","volume":"28","author":"Verhoef","year":"2001","journal-title":"J Rheumatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02503.x_bb0180","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00001721-200004001-00003","article-title":"Models of blood coagulation","volume":"11","author":"Butenas","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1160\/TH04-02-0112","article-title":"Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature","volume":"92","author":"Van Dijk","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0190","first-page":"925","article-title":"Factor V Leiden improves in vivo hemostasis in murine hemophilia models","volume":"4","author":"Schlachterman","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0195","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/09537100600757448","article-title":"Platelet-dependent coagulation assays for factor VIII efficacy measurments after substitution therapy in patients with haemophilia A","volume":"17","author":"Bassus","year":"2006","journal-title":"Platelets"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1538-7836.2005.01181.x","article-title":"Does activated protein C-resistant factor V contribute to thrombin generation in haemophilic plasma?","volume":"3","author":"Bos","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02503.x_bb0205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1538-7836.2007.02447.x","article-title":"Phenotype of severe hemophilia A and plasma levels of risk factors for thrombosis","volume":"5","author":"Van Dijk","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02503.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02503.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:46:24Z","timestamp":1761533184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622175938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":40,"alternative-id":["S1538783622175938"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02503.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic heterogeneity in severe hemophilia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02503.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}